Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;57(3):219.
doi: 10.3390/medicina57030219.

Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia

María-Teresa Álvarez Román  1 , Víctor Jiménez Yuste  1   2 , Sara García Barcenilla  1 , Andrés Ramírez López  1 , Elena Monzón Manzano  1 , Beatriz de la Cruz Benito  1 , Paula Acuña Butta  1 , María Isabel Rivas Pollmar  1 , Roberto Trelles Martínez  1 , Elena González Zorrilla  1 , Mónica Martín Salces  1 , Tamara Cebanu  1 , Nora V Butta  1
Affiliations

Impact of COVID-19 Pandemic on Patients with Immune Thrombocytopaenia

María-Teresa Álvarez Román et al. Medicina (Kaunas). .

Abstract

Background and Objectives: The aim of this study was to determine the impact of the COVID-19 pandemic on the lives of patients with immune thrombocytopaenia (ITP) treated at our hospital. Materials and Methods: The study was conducted in the Community of Madrid, which has the highest number of COVID-19 cases in Spain. We included 143 adult patients with ITP (130 with chronic ITP, 8 with persistent ITP, and 5 with newly diagnosed ITP). We conducted a telephone survey to collect the data and created a registry. Materials and Methods: Overall, 24 patients presented symptoms suggestive of COVID-19, which was confirmed by RT-PCR in 8 cases. The cumulative incidence of confirmed SARS-CoV-2 infection was higher in the patients with ITP than in the Madrid population. There were no differences in the disease incidence or clinical course of infection in the patients treated with immunosuppressants. Almost all of the patients reported adherence to the prescribed treatment, although 49.2% of the hospital visits were either cancelled or postponed, 17.2% because of the patients' fear of coming to the centre. Nearly half of the cohort was considered vulnerable, and 17% had been granted a dependency or disability benefit. Conclusions: COVID-19 had a major impact on the psychosocial, occupational, and quality of care of patients with ITP.

Keywords: COVID-19; immune thrombocytopaenia; telemedicine; vulnerable population.

PubMed Disclaimer

Conflict of interest statement

M.-T.Á.R. and V.J.Y. have participated as speakers in advisory boards and sponsored symposia by Novo Nordisk, Takeda, Roche, Pfizer, Octapharma, Amgen, Novartis, CSL Behring, and Sobi. N.V.B. has participated as a speaker for Novo Nordisk, Takeda, Roche, Pfizer, and Novartis. S.G.B. has participated as a speaker at sponsored symposia by Novo Nordisk, Takeda, Roche, Pfizer, Novartis, and Sobi. E.M.M. holds a predoctoral fellowship from Fundación Española de Trombosis y Hemostasia (FETH-SETH). The rest of the authors have not conflict of interest to declare. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Similar articles

See all similar articles

Cited by

References

    1. Borobia A.M., Carcas A.J., Arnalich F., Alvarez-Sala R., Monserrat-Villatoro J., Quintana M., Figueira J.C., Torres Santos-Olmo R.M., Garcia-Rodriguez J., Martin-Vega A., et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. J. Clin. Med. 2020;9:1733. doi: 10.3390/jcm9061733. - DOI - PMC - PubMed
    1. Instituto Nacional de Estadística Población Residente por Fecha, S.Y.E.M., España. [(accessed on 26 April 2020)]; Available online: https://www.ine.es/
    1. Spiteri G., Fielding J., Diercke M., Campese C., Enouf V., Gaymard A., Bella A., Sognamiglio P., Sierra Moros M.J., Riutort A.N., et al. First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020. Euro Surveill. Bull. Eur. Mal. Transm. Eur. Commun. Dis. Bull. 2020;25 doi: 10.2807/1560-7917.ES.2020.25.9.2000178. - DOI - PMC - PubMed
    1. Alvarez-Roman M.T., De la Corte-Rodriguez H., Rodriguez-Merchan E.C., Martin-Salces M., Rivas-Pollmar M.I., Butta N.V., Garcia-Barcenilla S., Acuna P., Cebanu T., Gonzalez E., et al. COVID-19 and telemedicine in hemophilia in a patient with severe hemophilia A and orthopedic surgery. Haemophilia. 2020 doi: 10.1111/hae.14087. - DOI - PMC - PubMed
    1. Slomka A., Kowalewski M., Zekanowska E. Coronavirus disease 2019 (COVID-19): A short review on hematological manifestations. Pathogens. 2020;9:493. doi: 10.3390/pathogens9060493. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources